| Pharmaceutical active ingredients: |
| Benazepril HydrochlorideHydrochlorothiazide |
| Available forms, composition and doses of Lotensin HCT: |
| Tablets; Oral; Benazepril Hydrochloride 10 mg; Hydrochlorothiazide 12.5 mgTablets; Oral; Benazepril Hydrochloride 20 mg; Hydrochlorothiazide 12.5 mgTablets; Oral; Benazepril Hydrochloride 20 mg; Hydrochlorothiazide 25 mgTablets; Oral; Benazepril Hydrochloride 5 mg; Hydrochlorothiazide 6.25 mg |
| Lotensin HCT medical category: |
| Human:Angiotensin-Converting Enzyme inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03AX01 - Hydrochlorothiazide, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Related documents and information about Lotensin HCT: |
| Lotensin Novartis prescribing information (PDF)Lotensin HCT prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Benazepril; Hydrochlorothiazide | Benazepril Hydrochloride; Hydrochlorothiazide | Sandoz |
| Briazide | Benazepril Hydrochloride; Hydrochlorothiazide | Pierre Fabre |
| Cibadrex | Benazepril Hydrochloride; Hydrochlorothiazide | Novartis; Meda |
| Labodrex | Benazepril Hydrochloride; Hydrochlorothiazide | Novartis |
| Lotensin H | Benazepril Hydrochloride; Hydrochlorothiazide | Novartis |
| Lotensin Hctz | Benazepril Hydrochloride; Hydrochlorothiazide | Sandoz |
| Tensadiur | Benazepril Hydrochloride; Hydrochlorothiazide | Istituto Biochimico Nazionale Savio |
| Zinadiur | Benazepril Hydrochloride; Hydrochlorothiazide | Errekappa Euroterapici |
| Dilangio Compositum | Bencyclane Acefyllinate; Bencyclane Fumarate | Fournier |
| Angiociclan | Bencyclane Fumarate | Organon |